Translated automatically – community improvements welcome.
IL-6001
Trimipramine is a tricyclic antidepressant with sedative properties, primarily acting through the inhibition of norepinephrine and serotonin reuptake. Additionally, it blocks histamine and muscarinic acetylcholine receptors, contributing to its sedative effects. It is mainly used for the treatment of depression and sleep disorders. The side effect profile includes anticholinergic effects and sedation, necessitating a careful benefit-risk assessment.
Mechanism of Action
- NET inhibitor
- SERT inhibitor
Names / Identifiers
IUPAC: Trimipramine
Mechanism of Action
Trimipramine wirkt hauptsächlich als Hemmer der Wiederaufnahme von Serotonin und Noradrenalin, was zu einer Erhöhung der Verfügbarkeit dieser Neurotransmitter im synaptischen Spalt führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Acute myocardial infarction
- Pregnancy
- Breastfeeding
Known Risks
- medium
- Trimipramine kann Nebenwirkungen wie Schläfrigkeit, Mundtrockenheit und Gewichtszunahme verursachen.
Safer Use
- Regular medical monitoring.
- Avoidance of alcohol and other sedating substances.
Harm reduction tips do not replace medical advice.
Known Interactions
- MAO inhibitors
- other antidepressants
- alcohol
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.